Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 4.36 M3.48 M3.11 M7.7 M3.53 M5.15 M 19.48 M Research & development 813 K970 K679 K701 K878 K1.45 M 3.71 M Operating income -4.81 M-4.26 M-3.5 M-7.95 M-4.02 M-6.05 M -21.52 M Non-Operating Income, Total 1.09 M1.12 M1.09 M5.8 M828 K800 K 8.52 M Interest expense, net of interest capitalized 9 0005 0009 0009 0009 0009 000 36 K Non-Operating Income, excl. Interest Expenses 1.11 M1.09 M1.06 M960 K839 K800 K 3.66 M Unusual income/expense -19 K27 K23 K4.83 M-20 K-9 000 4.83 M Pretax income -3.72 M-3.14 M-2.41 M-2.14 M-3.19 M-5.25 M -13 M Equity in earnings —————— — Taxes 000-19 K00 -19 K Non-controlling/minority interest —————— — After tax other income/expense -132 K-61 K-42 K842 K-109 K-96 K 595 K Net income before discontinued operations -3.72 M-3.14 M-2.41 M-2.13 M-3.19 M-5.25 M -12.98 M Discontinued operations —————— — Net income -3.72 M-3.14 M-2.41 M-2.13 M-3.19 M-5.25 M -12.98 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -3.72 M-3.14 M-2.41 M-2.13 M-3.19 M-5.25 M -12.98 M Basic earnings per share (Basic EPS) -0.18-0.16-0.12-0.11-0.16-0.26 -0.65 Diluted earnings per share (Diluted EPS) -0.18-0.16-0.12-0.11-0.16-0.26 -0.65 Average basic shares outstanding 20.17 M20.17 M20.18 M20.18 M20.19 M20.43 M — Diluted shares outstanding 20.17 M20.17 M20.18 M20.18 M20.19 M20.43 M — EBITDA —————— — EBIT -4.81 M-4.26 M-3.5 M-7.95 M-4.02 M-6.05 M -21.52 M Cost of revenue 329 K265 K335 K333 K158 K248 K 1.07 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —